Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
RANKL Inhibition for Dense Breasts
Recruiting0 awardsPhase 2
Saint Louis, Missouri
This trial will test whether or not a drug that inhibits RANKL decreases mammographic density in high-risk premenopausal women with dense breasts, which could lead to new ways to prevent breast cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service